{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T19:54:25Z","timestamp":1760644465000,"version":"3.30.1"},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,5,14]],"date-time":"2002-05-14T00:00:00Z","timestamp":1021334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:p>Background.\u2002Chronic allograft dysfunction (CAD), the major cause of the failure of kidney allografts, may be caused by immunological and non\u2010immunological haemodynamic factors. Renin\u2013angiotensin system has been implicated in the development of intraglomerular hypertension and has a central role on progression in chronic renal disease. Polymorphism in 16th intron of the ACE gene has been reported to predict the circulating angiotensin II levels. The aim of this study was to investigate the effect of the both recipient and donor angiotensin converting enzyme (ACE) genotype on the development of CAD in renal allograft recipients.<\/jats:p><jats:p>Patients and methods.\u2002A total of 143 renal transplant recipients (95 male, 48 female, mean age 32\u2003\u00b1\u200310\u2003yr) were included. In order to exclude the effect of cold ischaemia, only patients transplanted from living donors were selected. Factors analysed in the development of CAD were donor and recipient age, past history of acute rejection, presence of hypertension and hypercholesterolaemia, serum uric acid level and ACE gene polymorphism.<\/jats:p><jats:p>Results.\u2002Forty of the patients (28%) had CAD. Homozygous deletion type ACE gene polymorphism was detected in 59 renal transplant recipients (42%) and in 31 donors of the patients (37%). On comparing patients with and without CAD, donor age, rate of acute rejection and hypertension and serum uric acid levels were significantly higher in CAD (+) groups. Neither recipient nor donor ACE genotype was associated with time to CAD. Cox regression analysis revealed donor age (p<jats:italic>\u2003<\/jats:italic>&lt;\u20030.001), presence of hypertension (p=0.002) and serum uric acid levels (p=0.009), but neither donor nor recipient ACE genotype as independent factors for predicting development of CAD.<\/jats:p><jats:p>Conclusion.\u2002Donor age, presence of hypertension and serum uric acid levels was independent factors. Donor and recipient ACE genotype seemed to have no influence on the development of CAD in living donor transplanted patients.<\/jats:p>","DOI":"10.1034\/j.1399-0012.2002.01058.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T13:49:56Z","timestamp":1047390596000},"page":"173-179","source":"Crossref","is-referenced-by-count":13,"title":["The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients"],"prefix":"10.1111","volume":"16","author":[{"given":"Alaattin","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halil","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naci","family":"\u00c7ine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vakur","family":"Akkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S Mehmet","family":"Kayacan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet S\u00fckr\u00fc","family":"Sever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihan","family":"Erginel\u2010\u00dcnaltuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,5,14]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.269"},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ajh\/4.7.623","article-title":"Plasma renin activity in renal transplant patients with hypertension","volume":"4","author":"BRESTICKER M","year":"1991","journal-title":"Am J Hypertens"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1681\/ASN.V22s37","article-title":"Pathophysiology and treatment of posttransplant hypertension","volume":"2","author":"LUKE RG.","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114844"},{"key":"e_1_2_7_6_2","first-page":"197","article-title":"Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I\u2010converting enzyme (ACE) gene controls plasma ACE levels","volume":"51","author":"TIRET L","year":"1992","journal-title":"Am J Hum Genet"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045390"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91088-3"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70004-1"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90435-2"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.V9112075","article-title":"Risk factors for long\u2010term renal survival after renal transplantation: a role for angiotensin\u2010converting enzyme (insertion\/deletion) polymorphism?","volume":"9","author":"BROEKROELOFS J","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1681\/ASN.V881319","article-title":"Angiotensin\u2010converting enzyme genotype and renal allograft survival","volume":"8","author":"BEIGE J","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.3.735"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199902270-00008"},{"key":"e_1_2_7_15_2","unstructured":"DECLARATION OFHELSINKI. Recommendations Guiding Physicians in Biomedical research Involving Human Subjects 41th World Medical Assembly Hong Kong September 1989."},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.3.1215"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/20.6.1433-a"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503163321103"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199606150-00006"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V101167"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199611150-00009"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003023420901"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200008150-00012"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199706150-00013"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.1999.130308.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199706270-00006"},{"key":"e_1_2_7_27_2","first-page":"S125","article-title":"Hypercholesterolemia\u2010 A determinant of renal function loss and death in IDDM patients with nephropathy","volume":"45","author":"KROLEWSKI AS","year":"1994","journal-title":"Kidney Int"},{"key":"e_1_2_7_28_2","first-page":"51N","article-title":"Serum lipids in patients with chronic renal failure on long\u2010term, protein\u2010restricted diets","volume":"87","author":"MASCHIO G","year":"1989","journal-title":"Am J Med"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601043340103"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-10-199511150-00003"},{"key":"e_1_2_7_31_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","article-title":"Association of chronic kidney graft failure with recipient blood pressure","volume":"53","author":"OPELZ G","year":"1998","journal-title":"Collaborative Transplant Study Kidney Int"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.1999.130502.x"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.1.34"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.9682"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0012.2002.01058.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0012.2002.01058.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-0012.2002.01058.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T10:27:10Z","timestamp":1733567230000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-0012.2002.01058.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,14]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["10.1034\/j.1399-0012.2002.01058.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-0012.2002.01058.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"type":"print","value":"0902-0063"},{"type":"electronic","value":"1399-0012"}],"subject":[],"published":{"date-parts":[[2002,5,14]]}}}